Statistics
Total Visits
| Views | |
|---|---|
| Paclitaxel and gemcitabine vs. paclitaxel and pegylated liposomal doxorubicin in advanced non-nasopharyngeal head and neck cancer. An efficacy and cost analysis randomized study conducted by the Hellenic Cooperative Oncology Group | 117 |
Total Visits Per Month
| February 2024 | March 2024 | April 2024 | May 2024 | June 2024 | July 2024 | August 2024 | |
|---|---|---|---|---|---|---|---|
| Paclitaxel and gemcitabine vs. paclitaxel and pegylated liposomal doxorubicin in advanced non-nasopharyngeal head and neck cancer. An efficacy and cost analysis randomized study conducted by the Hellenic Cooperative Oncology Group | 1 | 2 | 1 | 5 | 3 | 2 | 0 |
Top country views
| Views | |
|---|---|
| Poland | 54 |
| United States | 45 |
| Ireland | 4 |
| Sweden | 3 |
| France | 2 |
| India | 2 |
| Russia | 2 |
| Argentina | 1 |
| Australia | 1 |
| Canada | 1 |
Top cities views
| Views | |
|---|---|
| Warsaw | 54 |
| Louisville | 10 |
| San Ramon | 8 |
| Boardman | 5 |
| Des Moines | 4 |
| Dublin | 4 |
| Mountain View | 4 |
| San Diego | 3 |
| San Mateo | 3 |
| Ann Arbor | 2 |